Aarti Drugs surged 5.94% to Rs 377 at 11:22 IST on BSE after net profit jumped 58.94% to Rs 21.95 crore on 28.45% growth in total income from operations to Rs 283.04 crore in Q4 March 2014 over Q4 March 2013.
The Q4 result was announced after market hours on Wednesday, 30 April 2014. The stock market was closed on Thursday, 1 May 2014, on account of May Day.
Meanwhile, the S&P BSE Sensex was up 66.29 points or 0.3% at 22,484.09.
On BSE, so far 18,000 shares were traded in the counter as against average daily volume of 6,812 shares in the past one quarter.
The stock hit a high of Rs 388 so far during the day, which is a record high for the counter. The stock hit a low of Rs 374 so far during the day. The stock had hit a 52-week low of Rs 165 on 24 September 2013.
The stock had outperformed the market over the past one month till 30 April 2014, surging 35.07% compared with the Sensex's 0.35% rise. The scrip had also outperformed the market in past one quarter, jumping 55.19% as against Sensex's 9.36% rise.
More From This Section
The small-cap company has equity capital of Rs 12.11 crore. Face value per share is Rs 10.
Aarti Drugs' board of directors at its meeting held on Wednesday, 30 April 2014, recommended final dividend of Rs 5.50 per share for the year ended 31 March 2014 (FY 2014).
Aarti Drugs is a pharmaceutical company. The company makes generic bulk actives, advanced intermediates and specialty chemicals.
Powered by Capital Market - Live News